Market Overview

UPDATE: Morgan Stanley Downgrades V.F. Corporation to Equal-Weight


In a report published Monday, Morgan Stanley downgraded its rating on V.F. Corporation (NYSE: VFC) from Overweight to Equal-Weight and removed its $178 price target.

Morgan Stanley noted, “We continue to like VFC's business and believe in a large long-term growth potential; however, are a bit more cautious in the near term and see better risk/reward in RL and PVH at current levels. We believe top-line will slow for VFC in 2013 and cause slower EPS growth due to 1) weaker jeanswear business sales due to a weaker lower/middle income consumer and 2) The North Face and Timberland sales could decelerate driven by yet another warm winter, causing retailers to reconsider their ordering practices. We do not believe there is anything wrong with the The North Face brand but believe retailers could begin ordering the category more cautiously. We also believe Timberland's topline growth will be muted in 2013, as VFC continues to work on reinvigorating the brand for the long term. All of these factors cause us to lower our 2013 top-line revenue growth assumption to 6% and EPS to $10.73, below consensus of $11.00.”

V.F. Corporation closed on Friday at $144.17.

Latest Ratings for VFC

May 2019MaintainsNeutral
May 2019Initiates Coverage OnBuy
May 2019MaintainsNeutral

View More Analyst Ratings for VFC
View the Latest Analyst Ratings

Posted-In: Morgan StanleyAnalyst Color Downgrades Analyst Ratings


Related Articles (VFC)

View Comments and Join the Discussion!

Latest Ratings

HUBBInitiates Coverage On160.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at

Cowen and Company Reiterates Outperform Rating on Auxilium Pharmaceuticals

UPDATE: Morgan Stanley Upgrades PVH Corp. to Overweight, Reiterates $134 PT